The Checkup by Singlecare
DECEMBER 16, 2024
Theres nothing like biting into a sun-kissed orange, its juice filling your mouth with the refreshing taste of citrus. But if youre a person living with diabetes , you may wonder what effect the sweet treat will have on your blood sugar. You probably know that managing your blood sugar levels means being mindful of your carbohydrate intake and the glycemic index of your foods.
Drug Topics
DECEMBER 16, 2024
Experts conducted a study to better understand how ambulatory care pharmacist services impacted patient outcomes, provider workload, and access to care.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
DECEMBER 16, 2024
The approval builds on previous indications for tapinarof, an aryl hydrocarbon receptor agonist, for the topical treatment of atopic dermatitis.
Drug Topics
DECEMBER 16, 2024
Drug Topics met with Amanuel Kehasse, PharmD, PhD, to discuss the barriers surrounding biosimilar implementation in the prescription drug market.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
DECEMBER 16, 2024
Rural pharmacies and hospitals face unique challenges in maintaining adequate staffing and drug supply inventory to serve patients who often travel long distance.
Drug Topics
DECEMBER 16, 2024
Vtama from Organon was previously approved in May 2022 to treat plaque psoriasis in adults.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
DECEMBER 16, 2024
Two posters presented at the meeting looked into the topic CGMs in diabetes care.
Fierce Healthcare
DECEMBER 16, 2024
Medicare Advantage has steadily grown over the past decade, and now encompasses more than half of all seniors eligible for Medicare. | Medicare Advantage has steadily grown over the past decade, and now encompasses more than half of all seniors eligible for Medicare. However, over the past year, the industry has faced significant headwinds that have stymied some of their expansion plans.
Pharmacy Times
DECEMBER 16, 2024
Based on positive results from the HERCULES trial, the new designation will allow for more thorough regulatory review and development of the multiple sclerosis treatment.
STAT
DECEMBER 16, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Fighting back a hyper 6-year-old and his 3-year-old partner in crime as I attempt to write an intro here. My offspring say hello.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
DECEMBER 16, 2024
Nemolizumab exclusively targets IL-31 receptor alpha, inhibiting the signaling of IL-31, which drives disease mechanism in atopic dermatitis.
Fierce Healthcare
DECEMBER 16, 2024
Pharmacy benefit manager reform is included in a larger-than-anticipated healthcare package, but the PBM lobby is fighting the legislation at the eleventh hour. | With a deal closer than ever, the PBM industry is hoping to sow doubt over provisions in an end-of-year healthcare package.
Pharmacy Times
DECEMBER 16, 2024
Alison Moskowitz, MD, discusses the clinical considerations, dosing strategies, and the critical role of pharmacists in managing toxicities and tailoring treatment plans for dual-targeted therapy with ruxolitinib and duvelisib.
PharmaVoice
DECEMBER 16, 2024
With a little more certainty coming to the market, the R&D environment in 2025 will be about pipeline prioritization and accelerating M&A.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
DECEMBER 16, 2024
Obesity is associated with increased distant recurrence and breast cancer mortality in all types of early-stage breast cancer.
Fierce Healthcare
DECEMBER 16, 2024
Amae Health, a startup focused on severe mental illness, picked up a $6 million investment from Cedars-Sinai as it continues to grow its in-person clinics across the country. | Amae Health, a startup focused on severe mental illness, picked up a $6 million investment from Cedars-Sinai as it continues to grow its in-person clinics across the country.
Pharmaceutical Technology
DECEMBER 16, 2024
Discover the latest advancements in small cell lung cancer through Novotech CROs in-depth disease analysis.
Fierce Pharma
DECEMBER 16, 2024
Another checkpoint inhibitor has entered the fray, as Checkpoint Therapeutics has passed the FDAs checkpoint with its PD-L1 inhibitor cosibelimab. | Another checkpoint inhibitor has entered the fray, as Checkpoint Therapeutics has passed the FDAs checkpoint with its PD-L1 inhibitor cosibelimab.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
DECEMBER 16, 2024
The study authors add that the validation improved the risk score in additional community-acquired pneumonia cohorts, and clinical studies would assess the broad clinical applicability.
Fierce Pharma
DECEMBER 16, 2024
The FDA has blessed two previously approved medicinesone a cream and the other an injectionto treat atopic dermatitis (AD). | The FDA has blessed two previously approved medicinesone a cream and the other an injectionto treat atopic dermatitis (AD). On Monday, the agency signed off on Organons Vtama, a topical cream which was originally approved for plaque psoriasis in 2022.
Pharmacy Times
DECEMBER 16, 2024
Often used as a treatment for severe exacerbations of myasthenia gravis, intravenous immunoglobulin can lead to high financial toxicity and resource utilization.
Fierce Pharma
DECEMBER 16, 2024
Novo Nordisk blueprints $1.
Pharmacy Times
DECEMBER 16, 2024
Results of the study showed an inverse relationship between BMI and LDL cholesterol changes for those who adopt a low-carbohydrate diet.
Fierce Pharma
DECEMBER 16, 2024
After seven decades with no advances in the treatment of the genetic disorder classic congenital adrenal hyperplasia (CAH), Neurocrine Biosciences has
Pharmacy Times
DECEMBER 16, 2024
Panelists discuss how clinical management of CAR T-cell therapyassociated toxicities focuses primarily on early recognition and prompt intervention with tocilizumab and/or corticosteroids for cytokine release syndrome (CRS) and immune effector cellassociated neurotoxicity syndrome (ICANS), following established grading systems and treatment algorithms.
Fierce Pharma
DECEMBER 16, 2024
After clearing all regulatory hurdles associated with its proposed buyout of CDMO Catalent, Novo Holdings is nearly ready to unwrap its $16.5 billion present just in time for the holidays. | The companies have "fulfilled all regulatory closing conditions" for the pending buyout, according to a Saturday press release.
Pharmacy Times
DECEMBER 16, 2024
Panelists discuss understanding institutional protocols for managing cytokine release syndrome (CRS) and immune effector cellassociated neurotoxicity syndrome (ICANS) prophylaxis in bispecific antibody therapy, along with criteria for safely selecting patients for outpatient step-up dosing.
Pharmaceutical Technology
DECEMBER 16, 2024
Manufacturing practices are evolving to advance antibody drug conjugates (ADCs) for cancer treatment through a targeted approach.
Pharma Times
DECEMBER 16, 2024
New treatment could revolutionise care for HAE patients
Hospital Pharmacy Europe
DECEMBER 16, 2024
The General Pharmaceutical Council (GPhC) has been given the green light to introduce enhanced processes to its quality assurance of pharmacists education and training. The pharmacy regulator has been given approval by its governing council to carry out an annual survey of students and trainees about the quality of education and training they are receiving.
Fierce Healthcare
DECEMBER 16, 2024
Healthcare is a $4 trillion industry that is ripe for disruption and innovation. | Nominations are now open for Fierce Healthcare's Fierce 15 of 2025. Think you've got what it takes to make the list? Submit your company.
Pharma Mirror
DECEMBER 16, 2024
CPHI Milan the worlds largest pharma event hosted last month in Milan saw a new record attendance of 59,000 pharma executives buoyed by returning confidence and increased deal-making on site. The post Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance appeared first on Pharma Mirror Magazine.
Compounding Pharmacy of America
DECEMBER 16, 2024
Discover the benefits of BHRT, a natural solution for hormone imbalance. Learn how it relieves menopause symptoms, improves energy, and supports overall health. The post The Benefits of Bioidentical Hormone Replacement Therapy (BHRT) appeared first on Compounding Pharmacy of America.
Expert insights. Personalized for you.
98 
Let's personalize your content